Veterinary Biotechnology

Revolutionizing
Tick
Control

Integrated biotechnology solution: Vaccine + AI App + Digital Certification to revolutionize, track and monitor cattle herds.

Discover Our Solution About the Problem
93%
Proven Efficacy
+$20B
Annual Global Losses
+230M
Cattle Heads
The Global Problem

Significant Losses for Global Livestock

Ticks cause devastating impacts on cattle productivity, resulting in global losses of over US$ 20 billion annually.

Tick Impacts

  • Affects metabolic process (delays fattening and reduces lactation)
  • Diseases with high mortality rates ("Bovine Parasitic Sadness")
  • Longer time to slaughter and pasture use
  • Reduction in leather quality
  • Loss of up to 30% of calves in warmer regions
  • High impact on 70-80% of the herd
  • Acaricide residues create export barriers

Brazil

$4.5B
Annual losses
2.5M
Affected properties
+230M
heads

Global

+$20B
Total losses
368.5M
dogs
$5.8B
by 2032
Our Solution

Integrated Solution

We combine advanced biotechnology, artificial intelligence and digital certification to revolutionize tick control.

TickVax Vaccine

  • Advanced biotechnology with 18 components
  • 93% proven efficacy
  • No chemical residues
  • 7 months of protection
  • Recombinant proteins
Learn More

TickVax Track APP

  • Intelligent monitoring with AI
  • Embedded AI for detection
  • Guided image capture
  • Dashboards and reports
  • Verifiable digital seal
Learn More

Digital Certification

  • Verifiable QR quality seal
  • Tick-free batches
  • No chemical residues
  • Complete traceability
  • Access to premium markets
Learn More

Solution Synergy

The combination of TickVax vaccine with the Track app creates mutual potentiation, offering complete control and reliable certification for the global market.

Cutting-edge Biotechnology

TickVax Vaccine

Innovative vaccine based on specific recombinant proteins from tick saliva, offering effective and long-lasting protection.

18 Active Components

Specific recombinant proteins from tick saliva, developed with cutting-edge technology.

93% Efficacy

Proven in rigorous clinical studies, offering superior protection against infestations.

7 Months Protection

Long-lasting protection with single dose, reducing costs and facilitating herd management.

🐄
TickVax Bovine
🐕
TickVax Canine
🐎
TickVax Equine
93%
Efficacy

Proven Protection

TRL 6 completed, 12 months to commercialization

Intelligent Monitoring

TickVax Track

Digital Seal for Tick and Residue-Free Batches
App + AI + Certification for Monitoring and Traceability

Mobile App

iOS/Android with guided image/video capture
and on-device AI

Embedded AI

Local processing via TFLite/ONNX for precise offline detection

Cloud Backend

Dashboards, audit trails and automatic report generation

Certification

Verifiable QR seal with transparent and auditable metrics

Technical Architecture

  • Mobile: With native camera and QR/RFID reading
  • Identification: RFID UHF EPC Gen2, BLE/NFC integration
  • Web panel: With dashboards and audit trail
  • Interoperability: CSV/JSON, SISBOV and slaughterhouse integrations

Commercial Benefits

International Markets
EU, USA, Asia
Valorization
Slaughterhouse bonus
Traceability
Total transparency
ROI 300%+
5k head herds

Economic and Sanitary Impact

🚫

Eliminates Chemical Residues

Vaccine eliminates risk of chemical residues in meat/milk and reduces selective pressure

🌱

Strengthens ESG

Mitigates non-tariff barriers (EU/USA/Asia) and batch rejection

Market and Opportunities

Market Opportunities

$5.8B
Digital livestock technology by 2032
CAGR 13.3%
$8.53B
Cattle monitoring by 2030
CAGR 11.8%
368.5M
Dogs in key markets
Pet Market

International Sanitary Barriers

🇪🇺

European Union

Strict residue rules (MRLs), frequent audits

🇯🇵

Japan

Detailed traceability, zero tolerance for residues

🇺🇸

United States

FSIS/USDA with rigorous residue inspections

Digital seal + vaccine = strategic advantage to overcome non-tariff barriers
Team

Our Team

Specialists in biotechnology and innovative solutions

João Moretti

CEO - TickVax

Ejecutivo y Emprendedor con más de 20 años de experiencia en la creación, gestión y M&A de empresas tecnológicas, enfocado en inversiones y en la creación de startups innovadoras.

Rafael Tinoco

CFO

Entrepreneur and executive with over 20 years of experience in financial and strategic management. Specialist in M&A, investor acquisition, and management and implementation of new projects.

Dr. Isabel Kinney

Managing Partner

PhD in Parasitology from USP, CNPq researcher with over 15 years of experience in tick vaccine development.

Dr. Mauricio Scavassini

CSO

PhD from USP in Parasitology and Vaccinology, specialist in biotechnology with a focus on innovative solutions for animal health.

Rogerio Marcellino

CTO

Strategic and innovative leader with extensive experience in technology, specializing in the implementation of advanced digital solutions.

Get in Touch

Ready to Revolutionize Tick Control?

Contact us and discover how TickVax can transform your business

Contact Information

WhatsApp
+55 11 96442-7376
E-mails
contato@tickvaxbiotech.com
Business Hours
Monday to Friday: 8:00-18:00
Saturday: 8:00-12:00